
Amplifon S.p.A.
(AMP)
Select Model
Select Model
Neutral 47 (OpenAI - 5.2)
Action:ReiteratedDate:03/18/26
The score is weighed down primarily by weakening financial performance (margin compression, zero free cash flow in 2025, and elevated leverage) and very bearish technicals (below all major moving averages with negative MACD). Valuation is only modestly supportive due to the dividend yield, but the high P/E limits upside support.
Positive Factors
Clinic network & recurring servicesAmplifon's extensive retail clinic network and bundled business model (device sales plus tests, fittings, aftercare) produce recurring service revenues and high customer retention. This structural model supports steady revenue visibility, repeat spend across device lifecycles, and durable local market barriers over months.
Negative Factors
Margin compressionA multi-year decline in net margin to 3.8% reflects structural pressure from pricing, cost inflation or adverse mix. Persistently lower margins weaken retained earnings and reduce the company's ability to self-fund growth or absorb shocks, increasing risk to profitability and strategic flexibility over months.
Read all positive and negative factors
Positive Factors
Negative Factors
Clinic network & recurring servicesAmplifon's extensive retail clinic network and bundled business model (device sales plus tests, fittings, aftercare) produce recurring service revenues and high customer retention. This structural model supports steady revenue visibility, repeat spend across device lifecycles, and durable local market barriers over months.
Read all positive factors